Opinion
3dOpinion
The Evidence Challenging Gender-Affirming Care for Youth Is Clear. Why Won't Gatekeepers Let Doctors See It?
The Department of Health and Human Services just released its report on gender dysphoria. Its findings are impossible to ignore.
It remains unknown whether or not short-term androgen deprivation (STAD) improves survival among men with intermediate-risk prostate cancer (IRPC) treated with dose-escalated radiotherapy (RT).
Weekly administration of prophylactic tamoxifen is much less effective than the standard daily regimen in preventing the adverse breast effects induced by bicalutamide. Bicalutamide monotherapy is ...
Several regulatory concerns have hindered development of androgens as anabolic therapies, despite unequivocal evidence that testosterone supplementation increases muscle mass and strength in men; it ...
The addition of hormone therapy to radiotherapy improves overall survival in men with high-risk prostate cancer, over ...
aDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, China bDepartment of Oncology, Fudan University Shanghai Medical College, Shanghai, China ...
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
An International, Prospective, Open-label, Multi-center, Randomized Phase III Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) Versus Observation to Delay Castration or Disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results